Eli M. Wallace

Insider Reports History

Location
C/O Bridgebio Oncology Therapeutics, Inc, 256 E. Grand Avenue, Suite 104, South San Francisco, CA
Signature
/s/ Aaron Chan, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Eli M. Wallace:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BridgeBio Oncology Therapeutics, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 1.61M Oct 2, 2025 Direct

Insider Reports Filed by Eli M. Wallace

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BBOT BridgeBio Oncology Therapeutics, Inc. Oct 2, 2025 1 $0 4 Oct 6, 2025 Chief Executive Officer, Director
BBOT BridgeBio Oncology Therapeutics, Inc. Aug 26, 2025 1 $0 4 Aug 28, 2025 Chief Executive Officer, Director
BBOT BridgeBio Oncology Therapeutics, Inc. Aug 11, 2025 0 $0 3 Aug 18, 2025 Chief Executive Officer, Director